Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 30, 1055-1059, April 1, 1970]
© 1970 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Medina, D.
Right arrow Articles by DeOme, K. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Medina, D.
Right arrow Articles by DeOme, K. B.

Carcinogen-induced Mammary Tumors from Preneoplastic Nodule Outgrowths in BALB/c Mice1

D. Medina2 and K. B. DeOme

Department of Zoology and Its Cancer Research Genetics Laboratory, University of California, Berkeley, California 94720

The oncogenic effect of two chemical carcinogens, 7,12-dimethylbenz(a)anthracene and urethan, and of {gamma}-irradiation was tested on 2 of the D series of BALB/c nodule outgrowth lines, D1 and D2. All 3 agents increased the tumor-producting capabilities of nodule outgrowth line D1, and {gamma}-irradiation also increased the tumor-producing capabilities of nodule outgrowth line D2. The two chemical carcinogens were not tested on D2. The tumor-producing capabilities of the nodule outgrowth lines were dependent both on the particular carcinogen tested and on the nodule outgrowth line used. Nodule outgrowth line D1 treated with urethan or with 7,12-dimethylbenz(a)anthracene produced 76% and 64% tumors, respectively, whereas irradiated outgrowth line D1 produced only 22% tumors. Untreated D1 outgrowth produced only 4% tumors. On the other hand, irradiated outgrowth line D2 produced 61% tumors, whereas untreated D2 outgrowths produced 14% tumors.

Blood from carcinogen-treated mice and cell-free extracts of tumors arising in carcinogen-treated outgrowths were assayed for the presence of mammary tumor virus activity by the noduligenic assay. In addition, thin sections of carcinogen-treated outgrowths and tumors derived from carcinogen-treated outgrowths were examined under the electron microscope for the presence of A and B particles. Neither virus particles nor evidence of mammary tumor virus activity were encountered.

1 Supported by USPHS Grants CA 5045 and CA 05388 from the National Cancer Institute.

2 Recipient of NIH Predoctoral Fellowship 4-F01-GM-38, 779-02. Present address: Department of Anatomy, Baylor College of Medicine, Houston, Texas 77025.

Received 8/ 7/69. Accepted 10/ 9/69.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1970 by the American Association for Cancer Research.